{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T23:17:12Z","timestamp":1772839032009,"version":"3.50.1"},"reference-count":26,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2017,3,29]],"date-time":"2017-03-29T00:00:00Z","timestamp":1490745600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2017,3,29]],"date-time":"2017-03-29T00:00:00Z","timestamp":1490745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiol Drug Saf"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1002\/pds.4201","type":"journal-article","created":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T02:26:37Z","timestamp":1490840797000},"page":"685-693","source":"Crossref","is-referenced-by-count":13,"title":["Low-dose naltrexone and opioid consumption: a drug utilization cohort study based on data from the Norwegian prescription database"],"prefix":"10.1002","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3376-6761","authenticated-orcid":false,"given":"Guttorm","family":"Raknes","sequence":"first","affiliation":[{"name":"Regional Medicines Information and Pharmacovigilance Centre (RELIS); University Hospital of North Norway; Troms\u00f8 Norway"},{"name":"National Centre for Emergency Primary Health Care; Uni Research Health; Bergen Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6475-3368","authenticated-orcid":false,"given":"Lars","family":"Sm\u00e5brekke","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Health Sciences; UiT-The Arctic University of Norway; Troms\u00f8 Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,3,29]]},"reference":[{"key":"10.1002\/pds.4201-BIB0001|pds4201-cit-0002","unstructured":"Admin The corporate, political and scientific history of naltrexone [Internet] Gazorpa.com http:\/\/www.lowdosenaltrexone.org\/gazorpa\/History.html"},{"key":"10.1002\/pds.4201-BIB0002|pds4201-cit-0003","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.mehy.2008.06.048","article-title":"Low-dose naltrexone for disease prevention and quality of life","volume":"72","author":"Brown","year":"2009","journal-title":"Med Hypotheses"},{"issue":"2","key":"10.1002\/pds.4201-BIB0003|pds4201-cit-0004","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.22006","article-title":"Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis","volume":"68","author":"Cree","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1002\/pds.4201-BIB0004|pds4201-cit-0005","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1007\/s10620-011-1653-7","article-title":"Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trial","volume":"56","author":"Smith","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1002\/pds.4201-BIB0005|pds4201-cit-0006","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/pme.12345","article-title":"Off-label, low-dose naltrexone for refractory chronic low back pain","volume":"15","author":"Ghai","year":"2014","journal-title":"Pain Med"},{"key":"10.1002\/pds.4201-BIB0006|pds4201-cit-0007","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10067-014-2517-2","article-title":"The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain","volume":"33","author":"Younger","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1002\/pds.4201-BIB0007|pds4201-cit-0008","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1526-4637.2009.00613.x","article-title":"Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study","volume":"10","author":"Younger","year":"2009","journal-title":"Pain Med"},{"key":"10.1002\/pds.4201-BIB0008|pds4201-cit-0009","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.37734","article-title":"Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels","volume":"65","author":"Younger","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1002\/pds.4201-BIB0009|pds4201-cit-0010","unstructured":"Curetogether 138 fibromyalgia treatments compared [Internet] http:\/\/curetogether.com\/fibromyalgia\/ig\/treatment-effectiveness-vs-popularity"},{"key":"10.1002\/pds.4201-BIB0010|pds4201-cit-0011","unstructured":"Skard K Unknown medicine LDN gives hope to thousands of patients [Internet] http:\/\/www.tv2.no\/a\/5316228"},{"key":"10.1002\/pds.4201-BIB0011|pds4201-cit-0012","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/pds.4110","article-title":"A sudden and unprecedented increase in low dose naltrexone (LDN) prescribing in Norway. Patient and prescriber characteristics, and dispense patterns. A drug utilization cohort study","volume":"26","author":"Raknes","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1002\/pds.4201-BIB0012|pds4201-cit-0013","unstructured":"Norwegian Fibromyalgia Association [LDN-low dose naltrexone] [Internet] http:\/\/www.fibromyalgi.no\/content\/download\/109394\/486179\/file\/NFFs%20uttalelse%20om%20LDN.pdf"},{"key":"10.1002\/pds.4201-BIB0013|pds4201-cit-0014","unstructured":"Gluck D My experience with low dose naltrexone [Internet] http:\/\/www.ldnresearchtrust.org\/content\/my-experience-low-dose-naltrexone-david-gluck-md"},{"key":"10.1002\/pds.4201-BIB0014|pds4201-cit-0015","unstructured":"Admin Frequently-asked questions about low dose naltrexone (LDN) as a therapy for multiple sclerosis [Internet] Gazorpa.com http:\/\/www.lowdosenaltrexone.org\/gazorpa\/LDNFAQ.html"},{"key":"10.1002\/pds.4201-BIB0015|pds4201-cit-0016","unstructured":"Hauge S. [Questions and answers] [Internet] http:\/\/www.iscomplete.no\/cgi-bin\/hauge\/imaker?id=5776"},{"key":"10.1002\/pds.4201-BIB0016|pds4201-cit-0017","first-page":"129","article-title":"Establishment of the nationwide Norwegian Prescription Database (NorPD)-new opportunities for research in pharmacoepidemiology in Norway","volume":"18","author":"Furu","year":"2008","journal-title":"Nor J Epidemiol"},{"key":"10.1002\/pds.4201-BIB0017|pds4201-cit-0018","unstructured":"Norwegian Institute of Public Health [Internet] Norwegian Institute of Public Health 2016 http:\/\/www.fhi.no\/eway\/?pid=240"},{"key":"10.1002\/pds.4201-BIB0018|pds4201-cit-0019","unstructured":"Norwegian Institute of Public Health 2016 February 18 [Internet]. [A continued decline in sales of non-prescription painkillers] https:\/\/www.fhi.no\/nyheter\/2015\/fortsatt-nedgang-i-salg-av-reseptfr\/"},{"key":"10.1002\/pds.4201-BIB0019|pds4201-cit-0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-015-1774-6","article-title":"Prevalence of use of non-prescription analgesics in the Norwegian HUNT3 population: impact of gender, age, exercise and prescription of opioids","volume":"15","author":"Dale","year":"2015","journal-title":"BMC Public Health"},{"key":"10.1002\/pds.4201-BIB0020|pds4201-cit-0021","unstructured":"Sakshaug S Str\u00f8m H Blix HS Litleskare I Granum T. Drug consumption in Norway 2011-2015 [Internet] http:\/\/www.legemiddelforbruk.no\/download\/Legemiddelstatistikk_2016_WEB.pdf"},{"key":"10.1002\/pds.4201-BIB0021|pds4201-cit-0022","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejpain.2009.05.006","article-title":"Increasing use of opioids from 2004 to 2007-pharmacoepidemiological data from a complete national prescription database in Norway","volume":"14","author":"Fredheim","year":"2010","journal-title":"Eur J Pain"},{"key":"10.1002\/pds.4201-BIB0022|pds4201-cit-0023","unstructured":"Norwegian Institute of Public Health Statistics from the Norwegian Prescription Database [Internet] http:\/\/www.norpd.no\/"},{"key":"10.1002\/pds.4201-BIB0023|pds4201-cit-0024","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/0960327112450901","article-title":"Withdrawal syndrome caused by naltrexone in opioid abusers","volume":"33","author":"Hassanian-Moghaddam","year":"2014","journal-title":"Hum Exp Toxicol"},{"key":"10.1002\/pds.4201-BIB0024|pds4201-cit-0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1300\/J069v25n02_01","article-title":"Antagonist treatment of opioid withdrawal: translational low dose approach","volume":"25","author":"Mannelli","year":"2006","journal-title":"J Addict Dis"},{"key":"10.1002\/pds.4201-BIB0025|pds4201-cit-0026","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/pme.12704","article-title":"Low-dose naltrexone to prevent intolerable morphine adverse events: a forgotten remedy for a neglected, global clinical need","volume":"16","author":"Raffaeli","year":"2015","journal-title":"Pain Med"},{"key":"10.1002\/pds.4201-BIB0026|pds4201-cit-0027","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/jpet.300.2.588","article-title":"Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats","volume":"300","author":"Powell","year":"2002","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.4201","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pds.4201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T09:55:32Z","timestamp":1719136532000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.4201"}},"subtitle":["Low-dose Naltrexone and Opioid Consumption"],"short-title":[],"issued":{"date-parts":[[2017,3,29]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"URL":"https:\/\/doi.org\/10.1002\/pds.4201","archive":["Portico"],"relation":{},"ISSN":["1053-8569"],"issn-type":[{"value":"1053-8569","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3,29]]}}}